Experimental cancer therapy shows success in more than 70% of patients in global clinical trials
A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical trials.
3 Big Social Security Changes Are Coming in 2023. Here’s What Retirees Must Know
Social Security benefits are adjusted annually to account for inflation and rising wages.
The 3 Best Oil Stocks to Buy Before the End of 2022
These oil stocks are well positioned heading into the new year.
What Cathie Wood and Her Team Think About Crypto Right Now
Another disaster has hit crypto, but Cathie Wood and her team think there’s reason to be optimistic.
3 No-Brainer Stocks I’d Buy Right Now Without Hesitation
Long-term investors can beat the market with these three stocks.
3 Monster Growth Stocks to Buy in 2023 That Could Set You Up For Life
Few companies will have the longevity to deliver strong returns for decades, but these three could be among them.
3 Monster Growth Stocks to Buy in 2023 That Could Set You Up For Life
Few companies will have the longevity to deliver strong returns for decades, but these three could be among them.
3 Software Stocks That Will Keep Your Retirement Account Safe
Yes, risk-averse investors can earn respectable returns.
1 ETF That Could Make You a Stock Market Millionaire With Little to No Effort
With the right investments, you could potentially make a lot of money in the stock market.
3 Cheap AI Stocks to Buy Before the End of 2022
It’s not often that tech stocks with high growth prospects get this cheap.
3 Cheap AI Stocks to Buy Before the End of 2022
It’s not often that tech stocks with high growth prospects get this cheap.
1 Super Stock Down 91% You’ll Wish You’d Bought on the Dip
Big changes are underway at this artificial intelligence powerhouse.
1 Super Stock Down 91% You’ll Wish You’d Bought on the Dip
Big changes are underway at this artificial intelligence powerhouse.
Better EV Stock: Canoo vs. Nikola
Which battered EV stock has a better shot at a comeback in 2023?